Literature DB >> 16303064

Biological false-positive tests comprise a high proportion of Venereal Disease Research Laboratory reactions in an analysis of 300,000 sera.

Alexandra Geusau1, Harald Kittler, Ulrike Hein, Edda Dangl-Erlach, Georg Stingl, Erwin Tschachler.   

Abstract

This retrospective study on syphilis screening at the sexually transmitted infection (STI) unit of a University Department emphasizes the necessity of a treponemal-specific test as the appropriate screening test. The Venereal Disease Research Laboratory (VDRL) test for syphilis screening may, under certain circumstances, yield positive results in patients not infected with Treponema pallidum, a phenomenon referred to as biological false-positive (BFP) VDRL test. The aim of this study was to determine the frequency of BFP tests in a large sample of sera. In this retrospective study, we analysed the results of parallel VDRL and T. pallidum haemagglutination (TPHA) testing of a total of 514,940 blood samples obtained from patients at the Vienna General Hospital between January 1988 and November 1999. Patients' sera with incomplete data on stage and sex and duplicate sera were excluded, leaving 300,000 sera for analysis. The seroprevalence for syphilis was 1.77% (n = 5320), as determined by a positive TPHA test. It was significantly higher in male than in female patients (2.03% versus 1.58%, P<0.001). Of the patients reactive in the TPHA test, 3257 (61.2%) were negative in the VDRL. With regard to reactivity in VDRL testing, 2799 patients (0.92%) of the study population were positive, of whom 736 (26%) were biological false positive. BFP reactivity was found in 0.24% of all patients and was significantly higher in women than in men (0.27% versus 0.20%, P<0.001) and in patients over 60 years of age (0.34%) as compared with those under 60 (0.25%, P<0.001). This proportion might be even higher, as reactivity in the VDRL at 1:0 and 1:2 dilutions without a positive treponemal test was not reported. The subgroup of HIV-positive patients (n = 1415) revealed a 10-fold higher rate of BFP tests (2.1% versus 0.24), an effect being statistically significant. In a low syphilis prevalence population, BFP reactions comprise a high proportion of all VDRL reactors. Therefore, the use of the VDRL as a screening procedure is challenged.

Entities:  

Mesh:

Year:  2005        PMID: 16303064     DOI: 10.1258/095646205774763207

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  14 in total

1.  Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis.

Authors:  Xiaohui Mo; Yuelan Jin; Yang Yang; Weizhong Hu; Weiming Gu
Journal:  Eur J Med Res       Date:  2010-02-26       Impact factor: 2.175

2.  False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: a case control study.

Authors:  Ryan C Maves; Katherine Dean; Nilda Gadea; Eric S Halsey; Paul C F Graf; Andres G Lescano
Journal:  Travel Med Infect Dis       Date:  2013-10-30       Impact factor: 6.211

3.  Laboratory Evaluation of a Commercially Available Rapid Syphilis Test.

Authors:  Lara E Pereira; Joshua McCormick; Tandin Dorji; Joseph Kang; Yongcheng Sun; Mayur Shukla; Andre Hopkins; John Deutsch; Ellen N Kersh; Kyle Bernstein; Yetunde F Fakile
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

4.  Frequency and Characteristics of Biological False-Positive Test Results for Syphilis Reported in Florida and New York City, USA, 2013 to 2017.

Authors:  James Matthias; Ellen J Klingler; Julia A Schillinger; Gayle Keller; Craig Wilson; Thomas A Peterman
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Serologic Testing for Syphilis: Benefits and Challenges of a Reverse Algorithm.

Authors:  Katherine Soreng; Roma Levy; Yetunde Fakile
Journal:  Clin Microbiol Newsl       Date:  2014-12-15

6.  Investigating latent syphilis in HIV treatment-experienced Ethiopians and response to therapy.

Authors:  Selamawit Girma; Wondwossen Amogne
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

7.  Evaluation of a particle gel immunoassay as a screening test for syphilis.

Authors:  S Borelli; A Monn; J Meyer; U Berger; H P Honegger; St Lautenschlager
Journal:  Infection       Date:  2009-01-23       Impact factor: 3.553

8.  Prenatal Transmission of Syphilis and Human Immunodeficiency Virus in Brazil: Achieving Regional Targets for Elimination.

Authors:  Rodrigo Cerda; Freddy Perez; Rosa Maria S M Domingues; Paula M Luz; Beatriz Grinsztejn; Valdilea G Veloso; Sonja Caffe; Jordan A Francke; Kenneth A Freedberg; Andrea L Ciaranello
Journal:  Open Forum Infect Dis       Date:  2015-05-22       Impact factor: 3.835

Review 9.  The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management.

Authors:  Melody Ren; Thomas Dashwood; Sharon Walmsley
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-06       Impact factor: 5.071

10.  Evaluation of the usefulness of Treponema pallidum hemagglutination test in the diagnosis of syphilis in weak reactive Venereal Disease Research Laboratory sera.

Authors:  Manju Bala; Aman Toor; Meenakshi Malhotra; Monika Kakran; Sumathi Muralidhar; V Ramesh
Journal:  Indian J Sex Transm Dis AIDS       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.